関連する実験動画
Updated: Apr 3, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
まとめ
糖尿病性ケトアシドーシスは,インスリン不足だけでなく,複数の要因によって引き起こされます. 重要な健康指標のモニタリングは,代謝不補償を予防または遅らせるのに役立ちます.
科学分野:
- エンドクリノロジー エンドクリノロジー
- メタボリック障害 メタボリック障害
背景:
- 糖尿病性ケトアシドーシス (DKA) は,歴史的に,絶対的なインスリン欠乏症にのみ起因していた.
- 新興の証拠は,DKA.の多因子のエチオロギーを示唆しています.
研究 の 目的:
- 糖尿病性ケトアシドーシスの基礎となる複雑な病原性メカニズムを解明する.
- DKA管理における合理的で予防的な治療戦略のパラメータを概説する.
主な方法:
- DKAの病理生理学に関する現在の理解のレビューと合成.
- 患者のモニタリングのための重要な代謝パラメータの特定.
主要な成果:
- DKAは,相対的なインスリン不足,ストレスホルモンの過剰,断食,脱水などの組み合わせによるものです.
- 体重,体温,呼吸率,意識,ケトヌーリア,グリコスウリアのモニタリングは極めて重要です.
結論:
- 単一の要因を防止することで,DKAの進行を軽減することができます.
- 特定の臨床症状 (精神状態の変化,体重減少>5%,タキプネア) は,入院を正当化します.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Diabetes: Symptoms, Diagnosis, and Complications
2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
957
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
957
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
491
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
491

